现代妇女(医学前沿)
現代婦女(醫學前沿)
현대부녀(의학전연)
Modern Women(Frontiers of Medicine)
2014年
8期
163-164
,共2页
门冬胰岛素%瑞格列奈%老年%2型糖尿病
門鼕胰島素%瑞格列奈%老年%2型糖尿病
문동이도소%서격렬내%노년%2형당뇨병
insulin aspart%repaglinide%elderly patients%type 2 diabetes
探讨门冬胰岛素联合瑞格列奈治疗老年患者2型糖尿病临床疗效及应用价值。选择我院治疗的老年2型糖尿病患者128例作为研究对象,随机分为观察组和对照组,对照组给予瑞格列奈治疗,观察组在对照组基础上给予门冬胰岛素治疗,观察治疗效果。观察组患者治疗后空腹血糖、餐后2h血糖、糖化血红蛋白降低幅度优于对照组,组间对比经统计学分析,差异有统计学意义(P<0.05)。两组患者治疗期间不良反应发生情况比较差异无统计学意义(P>0.05)。采用门冬胰岛素联合瑞格列奈治疗老年患者2型糖尿病疗效可靠,能够有效控制患者血糖情况,不增加不良反应,值得在临床上大力推广使用。
探討門鼕胰島素聯閤瑞格列奈治療老年患者2型糖尿病臨床療效及應用價值。選擇我院治療的老年2型糖尿病患者128例作為研究對象,隨機分為觀察組和對照組,對照組給予瑞格列奈治療,觀察組在對照組基礎上給予門鼕胰島素治療,觀察治療效果。觀察組患者治療後空腹血糖、餐後2h血糖、糖化血紅蛋白降低幅度優于對照組,組間對比經統計學分析,差異有統計學意義(P<0.05)。兩組患者治療期間不良反應髮生情況比較差異無統計學意義(P>0.05)。採用門鼕胰島素聯閤瑞格列奈治療老年患者2型糖尿病療效可靠,能夠有效控製患者血糖情況,不增加不良反應,值得在臨床上大力推廣使用。
탐토문동이도소연합서격렬내치료노년환자2형당뇨병림상료효급응용개치。선택아원치료적노년2형당뇨병환자128례작위연구대상,수궤분위관찰조화대조조,대조조급여서격렬내치료,관찰조재대조조기출상급여문동이도소치료,관찰치료효과。관찰조환자치료후공복혈당、찬후2h혈당、당화혈홍단백강저폭도우우대조조,조간대비경통계학분석,차이유통계학의의(P<0.05)。량조환자치료기간불량반응발생정황비교차이무통계학의의(P>0.05)。채용문동이도소연합서격렬내치료노년환자2형당뇨병료효가고,능구유효공제환자혈당정황,불증가불량반응,치득재림상상대력추엄사용。
Objective Discuss the insulin aspart combine nai raigor column treatment of elderly patients with type 2 diabetes clinical curative ef-fect and application value.methods Choose our hospital treatment of 128 cases of elderly patients with type 2 diabetes as the research object, were randomly divided into observation group and control group, control group given repaglinide treatment, observation group in the control group given on the basis of insulin aspart therapy, to observe the treatment effect..Result Observation group of patients after treatment, 2 h postprandial blood glucose, fasting glucose a1c reduction is better than that of control group, compared between groups after statistics analysis, the difference was statistically significant (P<0.05). Two groups of treatment in patients with adverse reactions occurred during the study there was no statisti-cally significant difference compared (P>0.05).Conclusion The insulin aspart associated repaglinide reliable efficacy in the treatment of elderly patients with type 2 diabetes, patients can effectively control blood sugar condition, no increase in adverse reactions, is worth popularizing in clinical use.